Nevertheless, it is essential that patients and healthcare professionals (HCPs) are aware of the right procedures to follow to prevent GI AEs from arising or, if they occur, to mitigate their effects and improve adherence and persistence to the treatment
Results Patient Sample and Characteristics Figure 2 shows the flowchart of patient inclusion
Liu Y, Yieh L, Yang T, Drinkenburg W, Peeters P, Steckler T, et al
While Wegovy is a type of GLP-1 medication, not all GLP-1 medications are Wegovy
[DOI] [PMC free article] [PubMed] [Google Scholar] 41.Andrews M.G., Mukhtar T., Eze U.C., Simoneau C.R., Ross J., Parikshak N., Wang S., Zhou L., Koontz M., Velmeshev D., Siebert C.V., Gemenes K.M., Tabata T., Perez Y., Wang L., Mostajo-Radji M.A., de Majo M., Donohue K.C., Shin D., Salma J., Pollen A.A., Nowakowski T.J., Ullian E., Kumar G.R., Winkler E.A., Crouch E.E., Ott M., Kriegstein A.R